Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

iBio (IBIO) Liabilities from Discontinued Operations (2022 - 2024)

iBio (IBIO) has disclosed Liabilities from Discontinued Operations for 3 consecutive years, with 1933000.0 as the latest value for Q1 2024.

  • On a quarterly basis, Liabilities from Discontinued Operations fell 0.57% to 1933000.0 in Q1 2024 year-over-year; TTM through Mar 2024 was 1933000.0, a 0.57% decrease, with the full-year FY2023 number at 1941000.0, up 3366.07% from a year prior.
  • Liabilities from Discontinued Operations was 1933000.0 for Q1 2024 at iBio, roughly flat from 1936000.0 in the prior quarter.
  • In the past five years, Liabilities from Discontinued Operations ranged from a high of 1947000.0 in Q4 2022 to a low of 56000.0 in Q2 2022.
  • A 3-year average of 1670857.14 and a median of 1939000.0 in 2023 define the central range for Liabilities from Discontinued Operations.
  • Peak YoY movement for Liabilities from Discontinued Operations: surged 3366.07% in 2023, then fell 0.57% in 2024.
  • iBio's Liabilities from Discontinued Operations stood at 1947000.0 in 2022, then decreased by 0.56% to 1936000.0 in 2023, then decreased by 0.15% to 1933000.0 in 2024.
  • Per Business Quant, the three most recent readings for IBIO's Liabilities from Discontinued Operations are 1933000.0 (Q1 2024), 1936000.0 (Q4 2023), and 1939000.0 (Q3 2023).